← Back to Search

Colored Filters and Lighting Preferences for Low Vision

N/A
Waitlist Available
Research Sponsored by Nova Southeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial is testing whether a new assessment tool, the LuxIQ/2, is better than the current standard (the OttLite Cobra) at determining which combination of colored filters and illumination intensity is best for patients with low vision.

Who is the study for?
This trial is for adults over 18 with low vision who struggle with reading tasks and are interested in trying colored filters in reading glasses. They should have had a low vision evaluation and want to improve their reading comfort. People with severe dry eye syndrome, those needing electronic magnification or non-visual aids, or anyone scoring less than 21 on the TICS-M cognitive test cannot participate.Check my eligibility
What is being tested?
The study tests if using tinted filters and specific lighting improves reading comfort for people with low vision. Participants will compare preferences between LuxIQ/2 determined lighting/filter settings versus OttLite Cobra lighting in both clinical and home environments.See study design
What are the potential side effects?
There are no direct side effects from participating in this trial as it involves non-invasive interventions like testing different colored filters and light settings during reading activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Ramulu's sustained reading test
Reading domain of Activity inventory
Secondary outcome measures
Changes in contrast sensitivity
Changes in near visual acuity

Trial Design

4Treatment groups
Experimental Treatment
Group I: Immediate exposure to near vision glasses with filtersExperimental Treatment1 Intervention
Participants immediately provided with near vision glasses with colored filters
Group II: Immediate exposure to OttLite CobraExperimental Treatment1 Intervention
Participants are examined with OttLite Cobra to determine preferred lighting followed by LuxIQ/2
Group III: Immediate exposure to LuxIQ/2Experimental Treatment1 Intervention
Participants are examined with LuxIQ/2 to determine preferred lighting as determined by device followed by examination with OttLite Cobra
Group IV: Delayed exposure to near vision glasses with filtersExperimental Treatment1 Intervention
Participants provided with near vision glasses with colored filters after 8 weeks of wearing clear near vision glasses
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Colored near reading glasses
2017
N/A
~50
Lighting as determined by LuxIQ/2 or OttLite Cobra
2017
N/A
~50

Find a Location

Who is running the clinical trial?

Nova Southeastern UniversityLead Sponsor
92 Previous Clinical Trials
11,630 Total Patients Enrolled
1 Trials studying Visual Impairment
16 Patients Enrolled for Visual Impairment

Media Library

Colored near reading glasses Clinical Trial Eligibility Overview. Trial Name: NCT03192722 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals currently participate in this clinical experiment?

"Clinicaltrials.gov displays that this trial is still gathering participants, with the initial post date being April 20th 2017 and most recent update on May 2nd 2022."

Answered by AI

How many subjects are enrolled in this clinical trial?

"Affirmatively, a perusal of clinicaltrials.gov reveals that this medical study is still recruiting patients. This experiment was initially posted on April 20th 2017 and has had its parameters updated as recently as May 2nd 2022. There are currently 50 vacancies at 1 site."

Answered by AI

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What site did they apply to?
Nova Southeastern University
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2
So Yeon Lee 2017. "Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03192722.
~5 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top